TWI731660B - Processing method for accelerating the dispersion of injection-type fillers by means of pressurization - Google Patents

Processing method for accelerating the dispersion of injection-type fillers by means of pressurization Download PDF

Info

Publication number
TWI731660B
TWI731660B TW109113830A TW109113830A TWI731660B TW I731660 B TWI731660 B TW I731660B TW 109113830 A TW109113830 A TW 109113830A TW 109113830 A TW109113830 A TW 109113830A TW I731660 B TWI731660 B TW I731660B
Authority
TW
Taiwan
Prior art keywords
accommodating space
accommodating
solvent
injection
mixture
Prior art date
Application number
TW109113830A
Other languages
Chinese (zh)
Other versions
TW202140090A (en
Inventor
林川元
林睿禹
Original Assignee
透策生技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 透策生技股份有限公司 filed Critical 透策生技股份有限公司
Priority to TW109113830A priority Critical patent/TWI731660B/en
Priority to CN202010967114.9A priority patent/CN113546539A/en
Application granted granted Critical
Publication of TWI731660B publication Critical patent/TWI731660B/en
Publication of TW202140090A publication Critical patent/TW202140090A/en

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D19/00Degasification of liquids
    • B01D19/0073Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042

Abstract

本發明提供一種利用加壓手段以加速注射式填充物分散的處理方法,包含:在第一容納空間和第二容納空間中分別容納溶劑和注射式填充物,該注射式填充物包含可溶的膠體溶質和不溶的分散質;將第一容納裝置、連接裝置與第二容納裝置相互連通;透過初步混合步驟使注射式填充物和溶劑形成一混合物;以及透過重複進行往復加壓混合步驟,使混合物的流速增加並形成剪切力以防止注射式填充物中的膠體溶質或分散質聚集,並且使其分別快速地且穩定地溶解和分散於溶劑中。The present invention provides a processing method for accelerating the dispersion of injection-type filling by means of pressurization, which comprises: accommodating a solvent and an injection-type filling in a first accommodation space and a second accommodation space respectively, and the injection-type filling contains a soluble Colloidal solute and insoluble dispersant; connect the first containment device, the connection device and the second containment device to each other; make the injection-type filler and the solvent form a mixture through the preliminary mixing step; and repeat the reciprocating pressure mixing step to make The flow rate of the mixture is increased and a shear force is formed to prevent the colloidal solutes or dispersoids in the injectable filling from aggregation, and to dissolve and disperse them in the solvent quickly and stably, respectively.

Description

利用加壓手段以加速注射式填充物分散的處理方法Processing method for accelerating the dispersion of injection-type fillers by means of pressurization

本發明涉及一種利用加壓手段以加速注射式填充物分散的處理方法,尤其是一種利用往復式(back-and-forth)加壓手段處理方法,用以加速用於醫學美容的注射式填充物的分散。 The present invention relates to a processing method using pressure means to accelerate the dispersion of injection-type fillings, in particular to a processing method using back-and-forth pressure means to accelerate injection-type fillings used for medical cosmetology Of dispersion.

注射式聚(D,L-乳酸)(injectable poly-D,L-lactic acid,PDLLA)是一種新興的刺激膠原蛋白增生的注射式填充物(injectable filler),可以透過注射填充於人體的軟組織,從而達成除皺、修飾輪廓或使組織豐盈等的醫學美容效果。PDLLA填充物包含PDLLA微球體(microsphere)和羥甲基纖維素(CMC)。PDLLA微球體是用於刺激膠原蛋白增生的成分,但是不溶於注射用溶劑(例如:注射用蒸餾水)中。羥甲基纖維素是一種水溶性高分子,溶解在注射用溶劑中可以成為膠體溶液,從而產生增加黏性、提供分散和懸浮作用等的效果,使PDLLA微球體能夠良好的分散並懸浮在注射用溶液中,並且,含有羥甲基纖維素的注射用溶液具有一定的黏度,在注射後可以更好地保留在目標組織中而不會轉移到其他組織。 Injectable poly (D, L- lactic acid) (injectable poly- D, L -lactic acid, PDLLA) is a new stimulation of collagen injectable fillers (injectable filler), may be filled in the soft tissue of the human body through injection, So as to achieve medical beauty effects such as wrinkle removal, contour modification or tissue plumping. The PDLLA filler contains PDLLA microspheres and hydroxymethyl cellulose (CMC). PDLLA microspheres are components used to stimulate collagen proliferation, but they are insoluble in injection solvents (for example, distilled water for injection). Hydroxymethyl cellulose is a water-soluble polymer that can become a colloidal solution when dissolved in a solvent for injection, which has the effect of increasing viscosity, providing dispersion and suspension, etc., so that PDLLA microspheres can be well dispersed and suspended in the injection In addition, the injection solution containing hydroxymethyl cellulose has a certain viscosity and can be better retained in the target tissue after injection without transferring to other tissues.

PDLLA填充物透過逐漸刺激膠原蛋白增生來達成醫學美容效果,相對於傳統上直接注射玻尿酸或膠原蛋白的方式可以使醫學美容的效果更加自然且持久。然而,在配製成注射用溶液的狀態下,PDLLA微球體由於水解而逐漸分解成乳酸,而羥甲基纖維素水膠(CMC hydrogel)也會逐漸水解。因此,PDLLA填充物在製備完成後需要透過冷凍乾燥保存,在臨用時才使用注射用溶劑加以還原(reconstitution)。 PDLLA fillers gradually stimulate the proliferation of collagen to achieve medical cosmetic effects. Compared with the traditional direct injection of hyaluronic acid or collagen, the medical cosmetic effects can be more natural and lasting. However, in the state of being formulated as a solution for injection, the PDLLA microspheres are gradually decomposed into lactic acid due to hydrolysis, and the hydroxymethyl cellulose hydrogel (CMC hydrogel) will also be gradually hydrolyzed. Therefore, the PDLLA filling needs to be stored by freeze-drying after the preparation is completed, and the injection solvent is used for reconstitution before use.

在上述還原步驟中,通常是將注射用溶劑添加到裝有冷凍乾燥的PDLLA填充物的樣品瓶中,並密封樣品瓶或轉移到離心管(或微量離心管)中進行混合。傳統上混合的方式分為手搖法(hand-shaking method)和漩渦法(vortex method)。在所需的填充物濃度較低的情況下,例如,以8mL的溶劑還原200mg的PDLLA填充物的情況下,可以使用手搖法進行混合,但是往往需要超過30分 鐘才能將其混合均勻。並且,在所需的填充物濃度較高的情況下,例如,以1.4mL的溶劑還原200mg的PDLLA填充物的情況下,較適合使用漩渦法進行混合。即,將裝有填充物和溶劑的樣品瓶或離心管放置在漩渦產生器(vortex generator)的振盪平台上然後下壓,以2700rpm的轉速使液體產生漩渦以輔助混合。然而,在上述濃度較高的情況下,即使透過漩渦法進行混合,需要超過1小時才能將其混合均勻。 In the above reduction step, the injection solvent is usually added to a sample bottle containing freeze-dried PDLLA filling, and the sample bottle is sealed or transferred to a centrifuge tube (or microcentrifuge tube) for mixing. Traditionally, mixing methods are divided into hand-shaking method and vortex method. In the case where the required filler concentration is low, for example, in the case of reducing 200 mg of PDLLA filler with 8 mL of solvent, the hand shake method can be used for mixing, but it often takes more than 30 minutes Zhong can mix it evenly. In addition, when the required filler concentration is high, for example, when 200 mg of PDLLA filler is reduced with 1.4 mL of solvent, it is more suitable to use the vortex method for mixing. That is, a sample bottle or centrifuge tube filled with a filler and a solvent is placed on an oscillation platform of a vortex generator and then pressed down, and the liquid is vortexed at a rotation speed of 2700 rpm to assist mixing. However, in the case of the above-mentioned high concentration, even if the mixing is carried out by the vortex method, it takes more than 1 hour to mix it uniformly.

並且,在上述使用手搖法或漩渦法的傳統臨用現配方法中存在的缺點是,即使透過漩渦法對流體產生高於手搖法的剪切力,以加速和提升PDLLA填充物在添加溶劑還原時的分散速度和效果,仍然相當耗時,而且在均勻分散後靜置30分鐘後,仍然會產生溶劑與填充物分層的現象(如圖13所示),使得傳統的臨用現配方法的使用條件更為嚴苛。對於相似的注射式聚(L-乳酸)(injectable PLLA)產品(包含PLLA、CMC和甘露醇),更需要耗時48小時才能均勻分散。 Moreover, the disadvantage of the above-mentioned traditional method of using hand-crank method or vortex method is that even if the vortex method generates a higher shear force on the fluid than the hand-crank method, it accelerates and enhances the PDLLA filler. The dispersing speed and effect of solvent reduction are still quite time-consuming, and after being evenly dispersed, after standing for 30 minutes, there will still be a phenomenon of separation between the solvent and the filler (as shown in Figure 13), making the traditional temporary use The conditions of use of the formulation method are more stringent. For similar injectable poly(L-lactic acid) (injectable PLLA) products (including PLLA, CMC and mannitol), it takes 48 hours to evenly disperse.

不能夠均勻分散的注射用填充物溶液,除了會造成目標組織的醫學美容效果不均勻之外,還可能因為填充物的聚集現象而產生丘疹(papule)、小瘤(nodule)等併發症。 A filler solution for injection that cannot be uniformly dispersed will not only cause uneven medical beauty effects of the target tissue, but also may cause complications such as papules and nodules due to the aggregation of the filler.

有鑒於上述問題,需要一種利用加壓手段以加速注射式填充物分散的處理方法,相較於漩渦產生器能夠提供更大的剪切力,從而能夠防止注射式填充物聚集,以縮短注射式填充物的分散所需時間,並且能夠提升其分散效果和穩定性。 In view of the above problems, there is a need for a processing method that uses pressurization to accelerate the dispersion of injection-type fillings. Compared with the vortex generator, it can provide greater shear force, so as to prevent the injection-type filling from gathering and shorten the injection-type filling. It takes time to disperse the filler, and can improve its dispersion effect and stability.

本發明提供一種利用加壓手段以加速注射式填充物分散的處理方法,包括:提供步驟,提供一第一容納裝置、一第二容納裝置和一連接裝置,其中,該第一容納裝置具有一第一容納空間,該第二容納裝置具有一第二容納空間,並且該連接裝置具有一連通的通道,該通道的截面積小於該第一容納裝置的截面積和該第二容納裝置的截面積;容納步驟,在該第一容納空間中容納一溶劑,並在該第二容納空間中容納一注射式填充物,該注射式填充物包含可溶於該溶劑的膠體溶質和不溶於該溶劑的分散質;連接步驟,將該第一容納裝置透過該連接裝置與該第二容納裝置連接,使該第一容納空間、該通道和該第二容納空間相互連通;初步混合步驟,對該第一容納空間中的該溶劑加壓以將該溶劑部分或完全地擠壓到該第二容納空間中,以使該注射式填充物和該溶劑形成一混合物;以及往復加壓混合步驟,包含:對該第二容納空間中的該混合物加壓以將該混合物部分或完全地擠壓到該第一容納空間中,然後對該第一容納空間中的該混合物加壓以將該混合物部分或完全地擠壓到該第二容納空間中;其中,透過重複進行該往復加壓混合步驟,使該混合物的流速增加並形成剪切力以防止該膠體溶質或該分散質聚集,從而使該膠體溶質均勻地溶解於該溶劑中,並且使該注射式填充物中的該分散質均勻地分散於該溶劑中。The present invention provides a processing method for accelerating the dispersion of injection-type fillings by means of pressurization, which includes the steps of providing a first containing device, a second containing device and a connecting device, wherein the first containing device has a A first accommodating space, the second accommodating device has a second accommodating space, and the connecting device has a communicating channel whose cross-sectional area is smaller than the cross-sectional area of the first accommodating device and the cross-sectional area of the second accommodating device Accommodating step, accommodating a solvent in the first accommodating space, and accommodating an injectable filler in the second accommodating space, the injectable filler containing colloidal solute soluble in the solvent and insoluble in the solvent Dispersing substance; connecting step, connecting the first containing device with the second containing device through the connecting device, so that the first containing space, the channel, and the second containing space are in communication with each other; the preliminary mixing step is for the first The solvent in the accommodating space is pressurized to partially or completely squeeze the solvent into the second accommodating space, so that the injection-type filling and the solvent form a mixture; and the reciprocating pressure mixing step includes: The mixture in the second accommodating space is pressurized to partially or completely squeeze the mixture into the first accommodating space, and then the mixture in the first accommodating space is pressurized to partially or completely Squeezed into the second containing space; wherein, by repeating the reciprocating pressure mixing step, the flow rate of the mixture is increased and a shear force is formed to prevent the colloidal solute or the dispersed substance from gathering, thereby making the colloidal solute uniform It is dissolved in the solvent, and the dispersoid in the injectable filling is uniformly dispersed in the solvent.

較佳地,該往復加壓混合步驟的總進行時間為30秒以下。Preferably, the total time of the reciprocating pressure mixing step is 30 seconds or less.

根據本發明一實施例,在該容納步驟中,在該第二容納空間中除了容納有該注射式填充物之外的部分還容納有第一空氣,並且,在該初步混合步驟和該往復加壓混合步驟之間進一步包括:空氣排除步驟,將該第一容納裝置與該連接裝置分離,並阻擋外部空氣進入該第一容納空間中;並且,對該第二容納空間中的該混合物加壓從而將該第二容納空間中的該第一空氣經由該連接裝置的該通道排出;然後,將該第一容納裝置重新與該連接裝置連接。According to an embodiment of the present invention, in the accommodating step, the part of the second accommodating space other than the injectable filling also contains the first air, and in the preliminary mixing step and the reciprocating adding The pressure mixing step further includes: an air removal step, separating the first accommodating device from the connecting device, and blocking external air from entering the first accommodating space; and pressurizing the mixture in the second accommodating space Thereby, the first air in the second accommodating space is discharged through the passage of the connecting device; then, the first accommodating device is connected to the connecting device again.

根據本發明一實施例,在該容納步驟中,該注射式填充物為團絮狀結構,包含表層部分和內芯部分,並且在該內芯部分中還包含第二空氣;在該初步混合步驟中,該溶劑浸潤該注射式填充物的表層部分並與該注射式填充物的該內芯部分中的該第二空氣形成一氣液界面,從而在該氣液界面中形成一氣泡,該第二空氣和該注射式填充物的該內芯部分被包含在該氣泡中;並且在該往復加壓混合步驟中,透過對該混合物加壓以使該混合物的流速增加並形成剪切力來破壞該氣泡,以使該溶劑進入該氣泡中,從而使該注射式填充物的該內芯部分中的該膠體溶質均勻地溶解於該溶劑中,並且使該注射式填充物的該內芯部分中的該分散質均勻地分散於該溶劑中。According to an embodiment of the present invention, in the containing step, the injectable filler has a flocculent structure, including a surface layer portion and an inner core portion, and the inner core portion further contains second air; in the preliminary mixing step In this case, the solvent infiltrates the surface part of the injectable filling and forms a gas-liquid interface with the second air in the inner core part of the injectable filling, thereby forming a bubble in the gas-liquid interface, and the second The air and the core part of the injectable filler are contained in the bubble; and in the reciprocating pressure mixing step, the flow rate of the mixture is increased by pressurizing the mixture to form a shear force to destroy the Air bubbles, so that the solvent enters the air bubbles, so that the colloidal solute in the inner core part of the injectable filling is uniformly dissolved in the solvent, and the inner core part of the injectable filling The dispersant is uniformly dispersed in the solvent.

較佳地,該第一容納裝置具有可調整的一第一容納空間,該第二容納裝置具有可調整的一第二容納空間。Preferably, the first accommodating device has an adjustable first accommodating space, and the second accommodating device has an adjustable second accommodating space.

較佳地,在該初步混合步驟中,透過減小該第一容納空間的容積來對該第一容納空間中的該溶劑加壓。Preferably, in the preliminary mixing step, the solvent in the first accommodating space is pressurized by reducing the volume of the first accommodating space.

較佳地,在該往復加壓混合步驟中,透過減小該第二容納空間的容積來對該第二容納空間中的該混合物加壓,並且透過減小該第一容納空間的容積來對該第一容納空間中的該混合物加壓。 Preferably, in the reciprocating pressure mixing step, the mixture in the second accommodating space is pressurized by reducing the volume of the second accommodating space, and the mixture in the second accommodating space is reduced by reducing the volume of the first accommodating space. The mixture in the first containing space is pressurized.

較佳地,在該空氣排除步驟中,透過減小該第二容納空間的容積來對該第二容納空間中的該混合物加壓。 Preferably, in the air removal step, the mixture in the second accommodating space is pressurized by reducing the volume of the second accommodating space.

根據本發明一實施例,該分散質包含選自由以下所組成的群組中的至少一種:聚(D,L-乳酸)(PDLLA);聚(L-乳酸)(PLLA);聚己內酯(PCL);玻尿酸(HA);羥基磷灰石(HAP);以及膠原蛋白(Collagen)。 According to an embodiment of the present invention, the dispersant includes at least one selected from the group consisting of: poly(D,L-lactic acid) (PDLLA); poly(L-lactic acid) (PLLA); polycaprolactone (PCL); Hyaluronic acid (HA); Hydroxyapatite (HAP); and Collagen.

根據本發明一實施例,該膠體溶質包含選自由以下所組成的群組中的至少一種:羧甲基纖維素(CMC);玻尿酸(HA);以及玻尿酸(HA)和磷酸鈣(TCP)的混合物。 According to an embodiment of the present invention, the colloidal solute includes at least one selected from the group consisting of: carboxymethyl cellulose (CMC); hyaluronic acid (HA); and hyaluronic acid (HA) and calcium phosphate (TCP) mixture.

根據本發明一實施例,該溶劑包含選自由以下所組成的群組中的至少一種:碳酸氫鈉(sodium bicarbonate)水溶液;注射用蒸餾水(sterile water for injection,SWFI);一般生理食鹽水(normal saline);利多卡因(lidocaine,麻醉藥);含腎上腺素的利多卡因(lidocaine with epinepbrine,lidocaine+E);以及甘露醇(mannitol)。 According to an embodiment of the present invention, the solvent includes at least one selected from the group consisting of: sodium bicarbonate (sodium bicarbonate) aqueous solution; sterile water for injection (SWFI); normal saline (normal saline); lidocaine (lidocaine, anesthetic); lidocaine with epinepbrine (lidocaine+E); and mannitol.

根據本發明一實施例,該分散質為多孔性的微球體。 According to an embodiment of the present invention, the dispersion is porous microspheres.

綜上所述,在本發明的利用加壓手段以加速注射式填充物分散的處理方法中,往復加壓混合步驟的總進行時間為30秒以下即可達成使注射式填充物均勻分散的效果,相對於現有技術需要花費20分鐘至48小時具有相當顯著的進步功效。 In summary, in the processing method of the present invention that uses pressure to accelerate the dispersion of injection-type fillers, the total time of the reciprocating pressure mixing step is less than 30 seconds to achieve the effect of uniformly dispersing the injection-type filler. Compared with the prior art, it takes 20 minutes to 48 hours to have a significant improvement effect.

此外,透過使用本發明的處理方法來分散注射式填充物,即使在均勻分散後靜置30分鐘之後仍維持均勻分散的效果,具有進步的分散穩定性。 In addition, by using the treatment method of the present invention to disperse the injection-type filler, the uniform dispersion effect is maintained even after being allowed to stand for 30 minutes after being uniformly dispersed, and the dispersion stability is improved.

另外,透過使用本發明的處理方法來分散的注射式填充物,不論溶劑的分散效果如何,注射式填充物都沒有產生聚集。並且在分散效果最佳的溶劑中的分散效果也優於現有技術,同樣證明本發明在分散注射式填充物方面具有相當顯著的進步功效。 In addition, the injectable filler dispersed by the processing method of the present invention does not cause aggregation of the injectable filler regardless of the dispersing effect of the solvent. In addition, the dispersion effect in the solvent with the best dispersion effect is also better than that of the prior art, which also proves that the present invention has a significant improvement effect in dispersing injection-type fillings.

在本發明的以下描述中,將在所屬技術領域具有通常知識者能夠輕易理解範圍內省略現有技術的詳細說明。 In the following description of the present invention, a detailed description of the prior art will be omitted to the extent that a person with ordinary knowledge in the relevant technical field can easily understand it.

如圖1所示,本發明的利用加壓手段以加速注射式填充物分散的處理方法,包含:提供步驟S10、容納步驟S20、連接步驟S30、初步混合步驟S40、空氣排除步驟S50、往復加壓混合步驟S60。以下將針對本發明詳細說明。 As shown in Figure 1, the processing method of the present invention for accelerating the dispersion of injection-type fillers by means of pressurization includes: providing step S10, containing step S20, connecting step S30, preliminary mixing step S40, air removal step S50, reciprocating adding Press mixing step S60. The present invention will be described in detail below.

參照圖2,在提供步驟S10中,準備第一容納裝置10、第二容納裝置20和連接裝置30。其中,第一容納裝置10、第二容納裝置20分別具有可調整容積的第一容納空間11、第二容納空間21,並且連接裝置30具有連通的通道(參照圖3)。其中,連接裝置30的通道的截面積分別小於第一容納裝置10和第二容納裝置20的截面積,使得該較小的截面積可以在後續的步驟中用於對溶劑40或者溶劑40和注射式填充物50組成的混合物加壓。2, in the providing step S10, the first accommodating device 10, the second accommodating device 20, and the connecting device 30 are prepared. Among them, the first accommodating device 10 and the second accommodating device 20 respectively have a first accommodating space 11 and a second accommodating space 21 with adjustable volumes, and the connecting device 30 has a communicating channel (refer to FIG. 3 ). Wherein, the cross-sectional area of the channel of the connecting device 30 is smaller than the cross-sectional area of the first containing device 10 and the second containing device 20, so that the smaller cross-sectional area can be used for the solvent 40 or the solvent 40 and the injection in the subsequent steps. The mixture of formula filling 50 is pressurized.

較佳地,第一容納裝置10和第二容納裝置20可以是針筒,可以利用其活塞調整第一容納空間11和第二容納空間21的容積,並且,該些針筒具有分別與連接裝置30的通道匹配的開口,以用於分別連接到連接裝置30的通道。Preferably, the first accommodating device 10 and the second accommodating device 20 can be syringes, the pistons of which can be used to adjust the volume of the first accommodating space 11 and the second accommodating space 21, and these syringes have respective connection devices The openings of the channels of 30 are matched for connecting to the channels of the connecting device 30 respectively.

接著,在容納步驟S20中,在第一容納空間11中加入溶劑40,並在第二容納空間21中加入注射式填充物50,注射式填充物50包含可溶於溶劑40的膠體溶質52和不溶於溶劑40的分散質51(參照圖6)。Next, in the accommodating step S20, the solvent 40 is added to the first accommodating space 11, and the injectable filler 50 is added to the second accommodating space 21. The injectable filler 50 contains a colloidal solute 52 that is soluble in the solvent 40 and The dispersoid 51 which is insoluble in the solvent 40 (refer to FIG. 6).

注射式填充物50可以是注射式聚(D,L-乳酸)(injectable poly- D,L-lactic acid),其為一種用於刺激膠原蛋白增生的醫學美容產品。 Injectable fillers 50 may be an injection of Poly (D, L- lactic acid) (injectable poly- D, L -lactic acid), which is a method for stimulating collagen medical cosmetic products.

溶劑40可以是例如:碳酸氫鈉(sodium bicarbonate)水溶液、注射用蒸餾水(sterile water for injection,SWFI)、一般生理食鹽水(normal saline)、利多卡因(lidocaine,麻醉藥)、含腎上腺素的利多卡因(lidocaine with epinephrine,lidocaine + E)或甘露醇(mannitol),較佳地為注射用蒸餾水(SWFI)。The solvent 40 may be, for example, an aqueous solution of sodium bicarbonate (sodium bicarbonate), distilled water for injection (sterile water for injection, SWFI), normal saline (normal saline), lidocaine (lidocaine, anesthetic), and epinephrine-containing Lidocaine with epinephrine (lidocaine + E) or mannitol, preferably distilled water for injection (SWFI).

分散質51可以是例如:聚(D,L-乳酸)(poly- D,L-lactic acid,PDLLA)、聚(L-乳酸)(PLLA)、聚己內酯(PCL)、玻尿酸 (HA)、羥基磷灰石(HAP)或膠原蛋白(Collagen),較佳地為聚(D,L-乳酸)(PDLLA)。 The dispersant 51 can be, for example, poly(D,L-lactic acid) (poly- D,L- lactic acid, PDLLA), poly(L-lactic acid) (PLLA), polycaprolactone (PCL), hyaluronic acid (HA) , Hydroxyapatite (HAP) or Collagen (Collagen), preferably poly(D,L-lactic acid) (PDLLA).

分散質51可以是一種多孔性的微球體,具有高密度的表面結構和中空的內部結構。The dispersant 51 may be a porous microsphere with a high-density surface structure and a hollow internal structure.

膠體溶質52可以是例如:羧甲基纖維素(carboxymethyl cellulose ,CMC)、玻尿酸 (hyaluronic acid ,HA),或者是玻尿酸 (HA)和磷酸鈣(tricalcium phosphate,TCP)的混合物,較佳地為羧甲基纖維素(CMC)。The colloidal solute 52 may be, for example, carboxymethyl cellulose (CMC), hyaluronic acid (HA), or a mixture of hyaluronic acid (HA) and calcium phosphate (tricalcium phosphate, TCP), preferably carboxymethyl cellulose (CMC), hyaluronic acid (HA). Methyl cellulose (CMC).

然後,在連接步驟S30中,將第一容納裝置10透過連接裝置30與第二容納裝置20連接,使第一容納空間11、連接裝置30的通道和第二容納空間21相互連通。Then, in the connecting step S30, the first accommodating device 10 is connected to the second accommodating device 20 through the connecting device 30, so that the first accommodating space 11, the passage of the connecting device 30, and the second accommodating space 21 are communicated with each other.

參照圖3,在一實施例中,連接裝置30可以是三向閥,具有三個通道30b、30c、30d,以及用於控制該三個通道30b、30c、30d的連通狀態的閥門30a。較佳地,可以使用相鄰(即,呈現直角的)的兩個通道30b、30c或30c、30d分別連接到第一容納裝置10和第二容納裝置20,以使往復加壓混合步驟S60時,分別操作第一容納裝置10和第二容納裝置20的兩隻手的角度為90度,更符合人體工學。3, in an embodiment, the connecting device 30 may be a three-way valve with three passages 30b, 30c, 30d, and a valve 30a for controlling the communication state of the three passages 30b, 30c, 30d. Preferably, two adjacent (that is, right-angled) channels 30b, 30c or 30c, 30d can be used to connect to the first containment device 10 and the second containment device 20, respectively, so that the reciprocating pressure mixing step S60 , The angle of the two hands respectively operating the first containing device 10 and the second containing device 20 is 90 degrees, which is more ergonomic.

參照圖4,在另一實施例中,連接裝置30可以替換為具有兩個通道31a、31b的L型管31。或者,連接裝置30可以替換為V型管(圖未顯示),較佳地,該V型管的通道可以由兩個具有60度至120度的夾角的分支通道構成,使得往復加壓混合步驟S60的進行更符合人體工學,更佳地為90度夾角的型態,即L型管。4, in another embodiment, the connecting device 30 can be replaced with an L-shaped tube 31 having two channels 31a, 31b. Alternatively, the connecting device 30 can be replaced with a V-shaped tube (not shown in the figure). Preferably, the channel of the V-shaped tube can be composed of two branch channels with an included angle of 60 degrees to 120 degrees, so that the reciprocating pressure mixing step The S60 is more ergonomically designed, and it is better to have a 90-degree angle, that is, an L-shaped tube.

接著,參照圖2,在初步混合步驟S40中,沿著A方向對第一容納裝置10的活塞加壓以減小第一容納空間11的容積,從而對第一容納空間11中的溶劑40加壓,以將溶劑40部分或完全地擠壓到第二容納空間21中,從而使注射式填充物50和溶劑40形成混合物(如圖5所示)。Next, referring to FIG. 2, in the preliminary mixing step S40, the piston of the first containing device 10 is pressurized along the A direction to reduce the volume of the first containing space 11, thereby adding the solvent 40 in the first containing space 11 Press to partially or completely squeeze the solvent 40 into the second accommodating space 21, so that the injectable filler 50 and the solvent 40 form a mixture (as shown in FIG. 5).

由於在容納步驟S20中,在第二容納空間21中除了容納有注射式填充物50之外的部分還容納有空氣(如圖2所示,以下稱為第一空氣60),因此,在初步混合步驟S40之後可以進一步進行空氣排除步驟S50以將第一空氣60排除。Since in the accommodating step S20, the part of the second accommodating space 21 other than the injection-type filler 50 is also accommodating air (as shown in FIG. 2, hereinafter referred to as the first air 60), therefore, in the preliminary After the mixing step S40, an air removal step S50 may be further performed to remove the first air 60.

進行空氣排除步驟S50的原因在於,如果在第一容納空間11、連接裝置30的通道和第二容納空間21的連通空間中存在有大量空氣,則這些空氣將會在該連通空間中佔據大量空間並且形成氣壓(約為1大氣壓),從而不利於後續的往復加壓混合步驟S60的進行。The reason for performing the air removal step S50 is that if there is a large amount of air in the communication space of the first accommodating space 11, the passage of the connecting device 30, and the second accommodating space 21, the air will occupy a large amount of space in the communication space. In addition, an air pressure (about 1 atmosphere) is formed, which is not conducive to the subsequent reciprocating pressure mixing step S60.

如圖7所示,在空氣排除步驟S50中,將第一容納裝置10與連接裝置30分離,並透過固定第一容納空間11的容積(即,保持第一容納裝置10的活塞位置不變)來阻擋外部空氣進入第一容納空間11中;並且,沿著C方向對第二容納裝置20的活塞加壓以減小第二容納空間21的容積,從而對第二容納空間21中的混合物加壓,以將第二容納空間21中的第一空氣60經由連接裝置30的通道30c排出;然後,將第一容納裝置10重新與連接裝置30連接(如圖9所示)。As shown in FIG. 7, in the air removal step S50, the first accommodating device 10 is separated from the connecting device 30, and the volume of the first accommodating space 11 is fixed through (that is, the piston position of the first accommodating device 10 is kept unchanged) To block external air from entering the first accommodating space 11; and pressurize the piston of the second accommodating device 20 along the C direction to reduce the volume of the second accommodating space 21, thereby adding to the mixture in the second accommodating space 21 Press to discharge the first air 60 in the second accommodating space 21 through the channel 30c of the connecting device 30; then, the first accommodating device 10 is reconnected with the connecting device 30 (as shown in FIG. 9).

或者,如圖8所示,也可以不將第一容納裝置10與連接裝置30分離,而是將連接裝置30的閥門30a轉換為使第二容納空間21與外部連通,並且關閉第一容納空間11與第二容納空間21的通道。由此,同樣地可以在阻擋外部空氣進入第一容納空間11的同時沿著C方向加壓以將第二容納空間21中的第一空氣60自連接裝置30的通道30d排出,然後再將閥門30a轉回如圖9所示的狀態以重新連接第一容納裝置10。Or, as shown in FIG. 8, the first accommodating device 10 and the connecting device 30 may not be separated, but the valve 30a of the connecting device 30 may be converted to connect the second accommodating space 21 with the outside, and closing the first accommodating space 11 and the second accommodating space 21 channel. Therefore, it is also possible to pressurize along the C direction while blocking the entry of external air into the first accommodating space 11 to discharge the first air 60 in the second accommodating space 21 from the passage 30d of the connecting device 30, and then the valve 30a is turned back to the state shown in FIG. 9 to reconnect the first receiving device 10.

最後,在往復加壓混合步驟S60中,首先,參照圖9,繼續沿著C方向對第二容納裝置20的活塞加壓以減小第二容納空間21的容積,從而對第二容納空間21中的混合物加壓以將混合物部分或完全地擠壓到第一容納空間11中;然後,參照圖10,再次沿著A方向對第一容納裝置10的活塞加壓以減小第一容納空間11的容積,從而對第一容納空間11中的混合物加壓以將混合物部分或完全地擠壓到第二容納空間21中。其中,透過重複進行往復加壓混合步驟S60,使連通的第一容納空間11和第二容納空間21中的混合物的流速增加並形成剪切力以防止膠體溶質52或分散質51聚集,從而使注射式填充物50中的膠體溶質52均勻地溶解於溶劑40中,並且使注射式填充物50中的分散質51均勻地分散於溶劑40中。Finally, in the reciprocating pressurization and mixing step S60, first, referring to FIG. 9, continue to pressurize the piston of the second accommodating device 20 along the C direction to reduce the volume of the second accommodating space 21, thereby increasing the volume of the second accommodating space 21. Pressurize the mixture to partially or completely squeeze the mixture into the first accommodating space 11; then, referring to FIG. 10, pressurize the piston of the first accommodating device 10 again along the A direction to reduce the first accommodating space 11 to pressurize the mixture in the first accommodating space 11 to partially or completely squeeze the mixture into the second accommodating space 21. Wherein, by repeating the reciprocating pressure mixing step S60, the flow rate of the mixture in the communicating first containing space 11 and the second containing space 21 is increased and a shear force is formed to prevent the colloidal solute 52 or the dispersoid 51 from gathering, thereby making The colloidal solute 52 in the injection-type filling 50 is uniformly dissolved in the solvent 40, and the dispersoid 51 in the injection-type filling 50 is uniformly dispersed in the solvent 40.

參照圖6,其為圖5的部分5A的局部放大示意圖。根據本發明一實施例,在容納步驟S20中,注射式填充物50為團絮狀結構,並且包含表層部分(如圖6的邊界B至邊界B’處)和內芯部分(如圖6的邊界B’以內的部分),並且在內芯部分中還包含第二空氣70;在初步混合步驟S40中,溶劑40浸潤注射式填充物50的表層部分而使注射式填充物50的表層部分澎潤(如邊界B’至邊界B’’處),並且,溶劑40還與內芯部分中的第二空氣70形成氣液界面(如邊界B’處),從而在氣液界面B’中形成氣泡,即,氣液界面B’為該氣泡的表面,第二空氣70和注射式填充物50的內芯部分被包含在該氣泡中;並且,在往復加壓混合步驟S60中,透過對混合物加壓以使混合物的流速增加並形成剪切力來破壞該氣泡,以使溶劑40進入該氣泡中,從而使注射式填充物50的內芯部分中的膠體溶質52均勻地溶解於溶劑40中,並且使注射式填充物50的內芯部分中的分散質51均勻地分散於溶劑40中,從而形成均勻的分散液80。Refer to FIG. 6, which is a partial enlarged schematic view of part 5A of FIG. 5. According to an embodiment of the present invention, in the accommodating step S20, the injection-type filler 50 has a flocculent structure and includes a surface layer part (from the boundary B to the boundary B'in FIG. 6) and an inner core part (as shown in FIG. 6). The part within the boundary B'), and the inner core part also contains the second air 70; in the preliminary mixing step S40, the solvent 40 infiltrates the surface part of the injection-type filling 50 to cause the surface part of the injection-type filling 50 to swell Wet (such as the boundary B'to the boundary B"), and the solvent 40 also forms a gas-liquid interface with the second air 70 in the inner core portion (such as the boundary B'), thereby forming in the gas-liquid interface B' The bubble, that is, the air-liquid interface B'is the surface of the bubble, and the second air 70 and the inner core portion of the injectable filler 50 are contained in the bubble; and, in the reciprocating pressure mixing step S60, the mixture The pressure is applied to increase the flow rate of the mixture and form a shearing force to break the bubbles, so that the solvent 40 enters the bubbles, so that the colloidal solute 52 in the inner core portion of the injectable filler 50 is uniformly dissolved in the solvent 40 , And the dispersoid 51 in the inner core portion of the injection-type filler 50 is uniformly dispersed in the solvent 40, thereby forming a uniform dispersion 80.

由於上述氣泡的氣液界面B’的表面張力會阻止溶劑40與注射式填充物50的均勻混合,所以需要透過破壞上述氣泡的氣液界面B’來加速混合。Since the surface tension of the gas-liquid interface B'of the bubbles prevents the solvent 40 from uniformly mixing with the injectable filler 50, it is necessary to accelerate the mixing by destroying the gas-liquid interface B'of the bubbles.

較佳地,本發明的往復加壓混合步驟S60的總進行時間為30秒以下即可達成使膠體溶質52均勻溶解並使分散質51均勻分散的效果(如圖11所示,其為圖5的部分5A在重複進行往復加壓混合步驟S60後的局部放大示意圖),相對於現有技術需要花費20分鐘至48小時具有相當顯著的進步功效。 Preferably, the total execution time of the reciprocating pressure mixing step S60 of the present invention is less than 30 seconds to achieve the effect of uniformly dissolving the colloidal solute 52 and uniformly dispersing the dispersing substance 51 (as shown in FIG. 11, which is shown in FIG. 5). The partial enlarged schematic diagram of the part 5A after repeating the reciprocating pressure mixing step S60), which has a significant improvement effect compared to the prior art, which takes 20 minutes to 48 hours.

如圖12所示,挑選4種常見的注射用溶劑:注射用蒸餾水(SWFI)、一般生理食鹽水(NS)、利多卡因(lidocaine)、含腎上腺素的利多卡因(lidocaine+E);以及用於對照的2種溶劑:具有強離子強度的碳酸氫鈉(NaHCO3)水溶液、作為強滲透性脫水劑的甘露醇(mannitol)。使用上述6種溶劑分別以3分鐘的時間浸潤一顆注射式填充物50。在沒有外力攪拌的情況下,SWFI和甘露醇由於具有最弱的離子強度而分散效果較好,這是因為較強的離子強度會造成較多的聚集(aggregation)。 As shown in Figure 12, select 4 common solvents for injection: distilled water for injection (SWFI), normal saline (NS), lidocaine (lidocaine), lidocaine with epinephrine (lidocaine+E); And two solvents for comparison: sodium bicarbonate (NaHCO 3 ) aqueous solution with strong ionic strength, and mannitol as a strong osmotic dehydrating agent. Each of the above 6 solvents was used to infiltrate one injection-type filling 50 in 3 minutes. Without external stirring, SWFI and mannitol have a better dispersion effect due to their weakest ionic strength, because stronger ionic strength will cause more aggregation.

為了進一步驗證本發明的處理方法的分散效果,使用本發明的處理方法,在兩個3mL針筒中分別加入200mg的注射式填充物和8mL的溶劑,並使用三向閥連接該兩個針筒,然後透過往復式(back-and-forth)加壓混合法,反覆將針筒內的混合物在兩個針筒之間加壓推送1分鐘,其中,僅需要30秒以內的時間即可達成均勻分散的效果,結果如圖15和圖16所示,圖15為使用往復式加壓混合法將注射式填充物在各種溶劑中進行分散1分鐘之後靜置30分鐘後的分散型態的照片,圖16為使用往復式加壓混合法將注射式填充物在各種溶劑中進行分散1分鐘之後的分散型態的顯微照片。 In order to further verify the dispersion effect of the treatment method of the present invention, using the treatment method of the present invention, two 3mL syringes were added with 200mg of injectable filler and 8mL of solvent respectively, and a three-way valve was used to connect the two syringes. Then through the back-and-forth pressure mixing method, the mixture in the syringe is repeatedly pushed between the two syringes for 1 minute, and it only takes less than 30 seconds to achieve uniform dispersion. The results are shown in Figure 15 and Figure 16. Figure 15 is a photograph of the dispersion state of the injection-type filling after being dispersed in various solvents for 1 minute using the reciprocating pressure mixing method and then standing for 30 minutes. 16 is a photomicrograph of the dispersion state of the injection-type filling after being dispersed in various solvents for 1 minute using the reciprocating pressure mixing method.

並且,使用漩渦法作為對照,在2mL微量離心管中加入200mg的注射式填充物和8mL的溶劑後,放置在一般漩渦產生器的振盪平台上並下壓,以2700rpm的轉速產生漩渦,對離心管內的混合物進行分散30分鐘,結果如圖13和圖14所示。圖13為使用漩渦法將注射式填充物在各種溶劑中進行分散30分鐘之後靜置30分鐘後的分散型態的照片,圖14為使用漩渦法將注射式填充物在各種溶劑中進行分散30分鐘後的分散型態的顯微照片。 In addition, using the vortex method as a control, 200 mg of syringe filling and 8 mL of solvent were added to a 2 mL microcentrifuge tube, and then placed on the shaking platform of a general vortex generator and pressed down to generate a vortex at 2700 rpm. The mixture in the tube was dispersed for 30 minutes, and the results are shown in Figs. 13 and 14. Fig. 13 is a photograph of the dispersion state of the injection-type filling after being dispersed in various solvents for 30 minutes using the vortex method and then standing for 30 minutes, and Fig. 14 is the dispersion state of the injection-type filling material being dispersed in various solvents by the vortex method 30 Photomicrograph of the dispersion pattern after minutes.

參照圖15,可以看出,透過使用本發明的處理方法來分散注射式填充物,即使在均勻分散後靜置30分鐘之後,在各種溶劑中的注射式填充物仍維持均勻分散而沒有與溶劑分層,相較於此,現有技術在經過漩渦產生器處理後靜置30分鐘之後出現注射式填充物與溶劑分層的現象(如圖13所示),本發明的分散穩定性良好,具有相當顯著的進步功效。 Referring to Figure 15, it can be seen that by using the processing method of the present invention to disperse the injection-type filling, even after being allowed to stand for 30 minutes after being uniformly dispersed, the injection-type filling in various solvents remains uniformly dispersed without being mixed with the solvent. In contrast to this, in the prior art, the injection-type filler and the solvent layered (as shown in Figure 13) after being allowed to stand for 30 minutes after being processed by the vortex generator. The present invention has good dispersion stability and has Very significant improvement effect.

並且,參照圖16,圖16為透過使用本發明的處理方法來分散的注射式填充物在均勻分散後拍攝的顯微照片(左圖和右圖分別使用SWFI和NS作為溶劑)。可以看出,不論在分散效果最佳的SWFI溶劑或在分散效果不佳的NS中,注射式填充物(如圖16中的黑點)都沒有產生聚集,相較於此,現有技術使用漩渦產生器處理的注射式填充物在分散效果不佳的NS溶劑中出現的嚴重的聚集現象(如圖14右圖),且在分散效果最佳的SWFI溶劑的分散效果(如圖14左圖)也不如本發明均勻,同樣證明本發明在分散注射式填充物方面具有相當顯著的進步功效。 And, referring to FIG. 16, FIG. 16 is a photomicrograph taken after uniform dispersion of the injection-type filling dispersed by using the processing method of the present invention (the left and right images use SWFI and NS respectively as solvents). It can be seen that no matter in the SWFI solvent with the best dispersion effect or in the NS with poor dispersion effect, the injection-type filler (the black dot in Figure 16) does not produce aggregation. In contrast, the prior art uses vortex The injection-type filler processed by the generator has serious aggregation in the NS solvent with poor dispersion effect (as shown in the right picture of Fig. 14), and the dispersion effect of the SWFI solvent with the best dispersion effect (as shown in the left picture of Fig. 14) It is not as uniform as the present invention, and it also proves that the present invention has a significant improvement effect in dispersing injectable fillings.

綜上所述,本發明的利用加壓手段以加速注射式填充物分散的處理方法,透過使用往復(back-and-forth)加壓方法,提供比傳統的手搖或漩渦產生方法更大的剪切力,足以防止注射式填充物中的膠體溶質或分散質的聚集,並且能夠破壞注射式填充物中的空氣所形成的氣泡,從而在短時間內產生良好的分散效果,並且在均勻分散後維持良好的穩定性。 In summary, the processing method of the present invention that uses pressurization to accelerate the dispersion of injection-type fillers, through the use of a back-and-forth pressurization method, provides greater than the traditional manual or vortex generation method The shear force is sufficient to prevent the aggregation of colloidal solutes or dispersants in the injection-type filling, and can destroy the bubbles formed by the air in the injection-type filling, so as to produce a good dispersion effect in a short time, and the dispersion is evenly dispersed. After maintaining good stability.

10:第一容納裝置 10: The first containment device

11:第一容納空間 11: The first accommodation space

20:第二容納裝置 20: second containment device

21:第二容納空間 21: second accommodation space

30:連接裝置 30: Connect the device

30a:閥門 30a: Valve

30b:通道 30b: Channel

30c:通道 30c: Channel

30d:通道 30d: channel

31:L型管 31: L-shaped tube

31a:通道 31a: Channel

31b:通道 31b: Channel

40:溶劑 40: Solvent

5A:部分 5A: Part

50:注射式填充物50: Injectable filler

51:分散質51: Dispersion

52:膠體溶質52: colloidal solute

60:第一空氣60: First Air

70:第二空氣70: second air

80:分散液80: dispersion

A:方向A: Direction

B:邊界B: boundary

B’:邊界、氣液界面B’: boundary, gas-liquid interface

B’’:邊界B’’: boundary

C:方向C: direction

S10:提供步驟S10: Provide steps

S20:容納步驟S20: containment step

S30:連接步驟S30: Connection steps

S40:初步混合步驟S40: Preliminary mixing steps

S50:空氣排除步驟S50: Air removal step

S60:往復加壓混合步驟S60: Reciprocating pressure mixing step

圖1為本發明的加速注射式填充物分散的處理方法流程圖;圖2為本發明的容納步驟的裝置示意圖;圖3為本發明的連接裝置的一個實施例的示意圖;圖4為本發明的連接裝置的另一實施例的示意圖;圖5為本發明的初步混合步驟的示意圖;圖6為圖5的初步混合步驟中的氣泡的局部放大圖;圖7為本發明的空氣排除步驟的一個實施例的示意圖;圖8為本發明的空氣排除步驟的另一實施例的示意圖;圖9為本發明的往復加壓混合步驟的示意圖,其中,透過減小第二容納裝置的容積以對其中的混合物進行加壓;圖10為本發明的往復加壓混合步驟的示意圖,其中,透過減小第一容納裝置的容積以對其中的混合物進行加壓;圖11為圖5的氣泡經過往復加壓混合步驟之後的局部放大圖;圖12為注射式填充物在各種溶劑中浸潤3分鐘後的分散型態的照片;圖13為使用漩渦產生器將注射式填充物均勻分散在各種溶劑中之後靜置30分鐘後的分散型態的照片;圖14為使用漩渦產生器將注射式填充物均勻分散在各種溶劑中的分散型態的顯微照片;圖15為使用本發明的處理方法將注射式填充物均勻分散在各種溶劑中之後靜置30分鐘後的分散型態的照片;以及圖16為使用本發明的處理方法將注射式填充物均勻分散在各種溶劑中的分散型態的顯微照片。 Fig. 1 is a flow chart of the processing method for accelerated injection-type filling dispersion of the present invention; Fig. 2 is a schematic diagram of the accommodating step device of the present invention; Fig. 3 is a schematic diagram of an embodiment of the connecting device of the present invention; Fig. 4 is the present invention Figure 5 is a schematic diagram of the preliminary mixing step of the present invention; Figure 6 is a partial enlarged view of the bubbles in the preliminary mixing step of Figure 5; Figure 7 is the air removal step of the present invention A schematic diagram of an embodiment; Figure 8 is a schematic diagram of another embodiment of the air removal step of the present invention; Figure 9 is a schematic diagram of the reciprocating pressure mixing step of the present invention, in which the volume of the second containing device is reduced to correct The mixture is pressurized; Figure 10 is a schematic diagram of the reciprocating pressure mixing step of the present invention, in which the mixture is pressurized by reducing the volume of the first containing device; Figure 11 is the bubble in Figure 5 after reciprocating Partial enlarged view after the pressure mixing step; Figure 12 is a photo of the dispersion state of the injection-type filling after being soaked in various solvents for 3 minutes; Figure 13 is the use of a vortex generator to uniformly disperse the injection-type filling in various solvents Then, it is a photo of the dispersion state after being allowed to stand for 30 minutes; Figure 14 is a photomicrograph of the dispersion state in which the injection-type filler is uniformly dispersed in various solvents using a vortex generator; Figure 15 is a photomicrograph of the dispersion state using the processing method of the present invention The injection-type filler is uniformly dispersed in various solvents and then is a photograph of the dispersion state after being allowed to stand for 30 minutes; and Figure 16 shows the dispersion state of the injection-type filler uniformly dispersed in various solvents using the processing method of the present invention. Micro photos.

S10:提供步驟 S10: Provide steps

S20:容納步驟 S20: containment step

S30:連接步驟 S30: Connection steps

S40:初步混合步驟 S40: Preliminary mixing steps

S50:空氣排除步驟 S50: Air removal step

S60:往復加壓混合步驟 S60: Reciprocating pressure mixing step

Claims (9)

一種利用加壓手段以加速注射式填充物分散的處理方法,包括:提供步驟,提供一第一容納裝置、一第二容納裝置和一連接裝置,其中,該第一容納裝置具有一第一容納空間,該第二容納裝置具有一第二容納空間,並且該連接裝置具有一連通的通道,該通道的截面積小於該第一容納裝置的截面積和該第二容納裝置的截面積;容納步驟,在該第一容納空間中容納一溶劑,並在該第二容納空間中容納一注射式填充物,該注射式填充物包含可溶於該溶劑的膠體溶質和不溶於該溶劑的分散質;連接步驟,將該第一容納裝置透過該連接裝置與該第二容納裝置連接,使該第一容納空間、該通道和該第二容納空間相互連通;初步混合步驟,對該第一容納空間中的該溶劑加壓以將該溶劑部分或完全地擠壓到該第二容納空間中,以使該注射式填充物和該溶劑形成一混合物;以及往復加壓混合步驟,包含:對該第二容納空間中的該混合物加壓以將該混合物部分或完全地擠壓到該第一容納空間中,然後對該第一容納空間中的該混合物加壓以將該混合物部分或完全地擠壓到該第二容納空間中;其中,透過重複進行該往復加壓混合步驟,使該混合物的流速增加並形成剪切力防止該膠體溶質或該分散質聚集,從而使該膠體溶質均勻地溶解於該溶劑中,並且使該分散質均勻地分散於該溶劑中;其中在該容納步驟中,在該第二容納空間中除了容納有該注射式填充物之外的部分還容納有第一空氣,並且,在該初步混合步驟和該往復加壓混合步驟之間進一步包括:空氣排除步驟,將該第一容納裝置與該連接裝置分離,並阻擋外部空氣進入該第一容納空間中;並且,對該第二容納空間中的該混合物加壓從而將該第二容納空間中的該第一空氣經由該連接裝置的該通道排出;然後,將該第一容納裝置重新與該連接裝置連接。 A processing method for accelerating the dispersion of injection-type fillings by means of pressurization includes the steps of providing a first containing device, a second containing device and a connecting device, wherein the first containing device has a first containing device. The second accommodating device has a second accommodating space, and the connecting device has a communicating channel, the cross-sectional area of the channel is smaller than the cross-sectional area of the first accommodating device and the cross-sectional area of the second accommodating device; the accommodating step Accommodating a solvent in the first accommodating space, and accommodating an injectable filler in the second accommodating space, the injectable filler comprising a colloidal solute that is soluble in the solvent and a dispersant that is insoluble in the solvent; In the connecting step, the first accommodating device is connected to the second accommodating device through the connecting device, so that the first accommodating space, the passage, and the second accommodating space communicate with each other; the preliminary mixing step is to connect the first accommodating space to the first accommodating space. The solvent is pressurized to partially or completely squeeze the solvent into the second accommodating space, so that the injection-type filling and the solvent form a mixture; and the reciprocating pressure mixing step includes: the second accommodating space The mixture in the accommodating space is pressurized to partially or completely squeeze the mixture into the first accommodating space, and then the mixture in the first accommodating space is pressurized to partially or completely squeeze the mixture into In the second containing space; wherein, by repeating the reciprocating pressure mixing step, the flow rate of the mixture is increased and a shear force is formed to prevent the colloidal solute or the dispersoid from gathering, so that the colloidal solute is uniformly dissolved in the In the solvent, and the dispersant is uniformly dispersed in the solvent; wherein in the containing step, the portion of the second containing space other than the injection-type filling is also contained in the first air, and , Between the preliminary mixing step and the reciprocating pressure mixing step, further comprising: an air removal step, separating the first containing device from the connecting device, and blocking outside air from entering the first containing space; and The mixture in the second accommodating space is pressurized to exhaust the first air in the second accommodating space through the passage of the connecting device; then, the first accommodating device is reconnected with the connecting device. 如請求項1之處理方法,其中,該往復加壓混合步驟的總進行時間為30秒以下。 Such as the processing method of claim 1, wherein the total execution time of the reciprocating pressure mixing step is 30 seconds or less. 如請求項1之處理方法,其中,在該容納步驟中,該注射式填充物為團絮狀結構,包含表層部分和內芯部分,並且在該內芯部分中還包含第二空氣;在該初步混合步驟中,該溶劑浸潤該注射式填充物的表層部分並與該注射式填充物的該內芯部分中的該第二空氣形成一氣液界面,從而在該氣液界面中形成一氣泡,該第二空氣和該注射式填充物的該內芯部分被包含在該氣泡中;並且在該往復加壓混合步驟中,透過對該混合物加壓以使該混合物的流速增加並形成剪切力來破壞該氣泡,以使該溶劑進入該氣泡中,從而使該注射式填充物的該內芯部分中的該膠體溶質均勻地溶解於該溶劑中,並且使該注射式填充物的該內芯部分中的該分散質均勻地分散於該溶劑中。 According to the processing method of claim 1, wherein, in the containing step, the injection-type filling has a flocculent structure, including a surface layer portion and an inner core portion, and the inner core portion further contains a second air; in the In the preliminary mixing step, the solvent infiltrates the surface part of the injectable filling and forms a gas-liquid interface with the second air in the inner core part of the injectable filling, thereby forming a bubble in the gas-liquid interface, The second air and the inner core portion of the injection-type filling are contained in the bubble; and in the reciprocating pressure mixing step, the flow rate of the mixture is increased by pressurizing the mixture and a shear force is formed To destroy the bubble, so that the solvent enters the bubble, so that the colloidal solute in the inner core portion of the injectable filling is uniformly dissolved in the solvent, and the inner core of the injectable filling The dispersoid in the part is uniformly dispersed in the solvent. 如請求項1之處理方法,其中,該第一容納裝置具有可調整的一第一容納空間,該第二容納裝置具有可調整的一第二容納空間;在該初步混合步驟中,透過減小該第一容納空間的容積來對該第一容納空間中的該溶劑加壓;並且在該往復加壓混合步驟中,透過減小該第二容納空間的容積來對該第二容納空間中的該混合物加壓,並且透過減小該第一容納空間的容積來對該第一容納空間中的該混合物加壓。 Such as the processing method of claim 1, wherein the first accommodating device has an adjustable first accommodating space, and the second accommodating device has an adjustable second accommodating space; in the preliminary mixing step, by reducing The volume of the first accommodating space is used to pressurize the solvent in the first accommodating space; and in the reciprocating pressure mixing step, the volume of the second accommodating space is reduced to reduce the volume of the second accommodating space. The mixture is pressurized, and the mixture in the first accommodation space is pressurized by reducing the volume of the first accommodation space. 如請求項1之處理方法,其中,該第一容納裝置具有可調整的一第一容納空間,該第二容納裝置具有可調整的一第二容納空間;在該初步混合步驟中,透過減小該第一容納空間的容積來對該第一容納空間中的該溶劑加壓;在該空氣排除步驟和該往復加壓混合步驟中,透過減小該第二容納空間的容積來對該第二容納空間中的該混合物加壓;並且在該往復加壓混合步驟中,透過減小該第一容納空間的容積來對該第一容納空間中的該混合物加壓。 Such as the processing method of claim 1, wherein the first accommodating device has an adjustable first accommodating space, and the second accommodating device has an adjustable second accommodating space; in the preliminary mixing step, by reducing The volume of the first accommodating space is used to pressurize the solvent in the first accommodating space; in the air removal step and the reciprocating pressure mixing step, the second accommodating space is reduced by reducing the volume of the second accommodating space. The mixture in the accommodating space is pressurized; and in the reciprocating pressure mixing step, the mixture in the first accommodating space is pressurized by reducing the volume of the first accommodating space. 如請求項1至5中任一項之處理方法,其中,該分散質包含選自由以下所組成的群組中的至少一種:聚(D,L-乳酸)(PDLLA);聚(L-乳酸)(PLLA);聚己內酯(PCL);玻尿酸(HA);羥基磷灰石(HAP);以及膠原蛋白(Collagen)。 The processing method according to any one of claims 1 to 5, wherein the dispersoid comprises at least one selected from the group consisting of: poly(D,L-lactic acid) (PDLLA); poly(L-lactic acid) ) (PLLA); polycaprolactone (PCL); hyaluronic acid (HA); hydroxyapatite (HAP); and collagen (Collagen). 如請求項1至5中任一項之處理方法,其中,該膠體溶質包含選自由以下所組成的群組中的至少一種:羧甲基纖維素(CMC);玻尿酸(HA);以及玻尿酸(HA)和磷酸鈣(TCP)的混合物。 The processing method according to any one of claims 1 to 5, wherein the colloidal solute comprises at least one selected from the group consisting of: carboxymethyl cellulose (CMC); hyaluronic acid (HA); and hyaluronic acid ( A mixture of HA) and calcium phosphate (TCP). 如請求項1至5中任一項之處理方法,其中,該溶劑包含選自由以下所組成的群組中的至少一種:碳酸氫鈉(sodium bicarbonate)水溶液;注射用蒸餾水(sterile water for injection,SWFI);一般生理食鹽水(normal saline);利多卡因(lidocaine,麻醉藥);含腎上腺素的利多卡因(lidocaine with epinephrine,lidocaine+E);以及甘露醇(mannitol)。 The processing method according to any one of claims 1 to 5, wherein the solvent comprises at least one selected from the group consisting of: sodium bicarbonate (sodium bicarbonate) aqueous solution; sterile water for injection (sterile water for injection, SWFI); normal saline (normal saline); lidocaine (lidocaine, anesthetic); lidocaine with epinephrine (lidocaine+E); and mannitol (mannitol). 如請求項1至5中任一項之處理方法,其中,該分散質為多孔性的微球體。 The processing method according to any one of claims 1 to 5, wherein the dispersion is porous microspheres.
TW109113830A 2020-04-24 2020-04-24 Processing method for accelerating the dispersion of injection-type fillers by means of pressurization TWI731660B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW109113830A TWI731660B (en) 2020-04-24 2020-04-24 Processing method for accelerating the dispersion of injection-type fillers by means of pressurization
CN202010967114.9A CN113546539A (en) 2020-04-24 2020-09-15 Treatment method for accelerating dispersion of injection filler by using pressurization means

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109113830A TWI731660B (en) 2020-04-24 2020-04-24 Processing method for accelerating the dispersion of injection-type fillers by means of pressurization

Publications (2)

Publication Number Publication Date
TWI731660B true TWI731660B (en) 2021-06-21
TW202140090A TW202140090A (en) 2021-11-01

Family

ID=77517303

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109113830A TWI731660B (en) 2020-04-24 2020-04-24 Processing method for accelerating the dispersion of injection-type fillers by means of pressurization

Country Status (2)

Country Link
CN (1) CN113546539A (en)
TW (1) TWI731660B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI338585B (en) * 2003-07-15 2011-03-11 Straumann Holding Ag System and method for mixing at least four components
US8267571B2 (en) * 2007-10-10 2012-09-18 OrtoWay AB Mixing system and mixing method for medical purposes
CN102770202A (en) * 2010-02-22 2012-11-07 药物混合系统股份公司 Syringe-like mixing device having a distally operable mixing element
CN102791242A (en) * 2010-03-10 2012-11-21 药物混合系统股份公司 Modular filling device for an applicator
CN107427644A (en) * 2015-02-19 2017-12-01 立方制药N·卡乐福列斯公司 Multicarity container

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH665127A5 (en) * 1983-12-02 1988-04-29 Debiopharm Sa COUPLING PART FOR INJECTION SYRINGES.
AT388503B (en) * 1987-05-21 1989-07-25 Immuno Ag SET FOR PROVIDING AND APPLICATION OF A TISSUE ADHESIVE
FR2749169B1 (en) * 1996-06-04 1998-08-21 Delab PROCESS FOR CONSTITUTING AN INJECTABLE PREPARATION AND DEVICE FOR CARRYING OUT SAID METHOD
US6328229B1 (en) * 1998-12-18 2001-12-11 Cohesion Technologies, Inc. Low volume mixing spray head for mixing and dispensing of two reactive fluid components
CN102805882B (en) * 2012-08-28 2014-04-23 华熙福瑞达生物医药有限公司 Method for mixing soft tissue filling agent with anesthetic injecta before use
US9421198B2 (en) * 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
EP3171918B1 (en) * 2014-07-22 2018-04-04 Orofino Pharmaceuticals Group S.r.l. Pre-filled injection device
TWI716365B (en) * 2014-11-13 2021-01-21 德商梅茲製藥有限兩合公司 Injectable dermal filler composition, a kit comprising the same, a method for preparing the same, and a use thereof
CN113828180A (en) * 2016-11-02 2021-12-24 米拉基创新智库有限公司 Apparatus and method for producing cold slurry for delivery to tissue in a patient
CN108619524A (en) * 2017-03-18 2018-10-09 浙江臻我生物技术有限公司 A kind of poly (lactic acid) composition and preparation method thereof
CN108619563A (en) * 2017-03-18 2018-10-09 浙江臻我生物技术有限公司 A kind of poly (lactic acid) composition and preparation method thereof
CN108619564A (en) * 2017-03-18 2018-10-09 浙江臻我生物技术有限公司 A kind of composition and preparation method thereof for skin filling

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI338585B (en) * 2003-07-15 2011-03-11 Straumann Holding Ag System and method for mixing at least four components
US8267571B2 (en) * 2007-10-10 2012-09-18 OrtoWay AB Mixing system and mixing method for medical purposes
CN102770202A (en) * 2010-02-22 2012-11-07 药物混合系统股份公司 Syringe-like mixing device having a distally operable mixing element
CN102791242A (en) * 2010-03-10 2012-11-21 药物混合系统股份公司 Modular filling device for an applicator
CN107427644A (en) * 2015-02-19 2017-12-01 立方制药N·卡乐福列斯公司 Multicarity container

Also Published As

Publication number Publication date
TW202140090A (en) 2021-11-01
CN113546539A (en) 2021-10-26

Similar Documents

Publication Publication Date Title
TWM602945U (en) Processing device for accelerating the dispersion of injection-type fillers by means of pressurization
CN111298196A (en) Polylactic acid porous microsphere, preparation method and application thereof
CN101784267B (en) Sustained-release chitosan capsules comprising chitosan and phytic acid
CN107007881A (en) Available for medicine loading and the injectable type self-healing gel discharged and its preparation method and application
CN104095761A (en) Polymer microneedle patch and application thereof
TWI731660B (en) Processing method for accelerating the dispersion of injection-type fillers by means of pressurization
CN105451713A (en) Silica hydrogel composite
CN105339022A (en) Hydrogel pressure sealant system
CN1244794A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
JP2012507396A (en) Multi-chamber mixing system
TWI745942B (en) Processing method of using negative pressure to accelerate the dispersion of injection-type filling
JP5805791B2 (en) Gelling collagen and means for supplying the same
JP2018510883A (en) Dissolvable microniddle for protein or peptide delivery
US20060233893A1 (en) Aqueous solutions for the reduction of fatty tissue
CN110087697A (en) Stop blooding flowable object
RU2213581C2 (en) Method for preparing composition for medicinal using
US10064673B2 (en) Osseous tissue delivery device
US20190269824A1 (en) Method for producing suspended form of ground decellularized extracellular matrix
US20180303532A1 (en) Delivery Device and Methods of Use
CN108079273A (en) For postanesthetic nursing scrub cream of local skin and preparation method thereof
KR102067490B1 (en) Hydrogel/nanoparticle composite with temperature sol-gel transition for sustained drug release
JP2720101B2 (en) W / O / W composite emulsion for injection and method for producing the same
CN113825529B (en) Inflatable microbubbles
JP2015524695A (en) Kit for filling connective tissue of skin, use and method thereof
Yanes et al. Poly-L-Lactic Acid